Raising the Tone: Lessons from the Past

By now you’ve probably heard of the ongoing saga at Valeant (VRX). The beleaguered pharmaceutical company has seen its stock plummet, questions about its accounting practices, harsh criticisms about its business practices, and turmoil among management and the board. A recent … Continue reading